Long-term nitric oxide exposure enhances lung cancer cell migration

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Sanuphan, Arpasinee ^a   Chunhacha, Preedakorn ^a   Pongrakhananon, Varisa ^a   Chanvorachote, Pithi ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; FOCAL ADHESION KINASE; NITRIC OXIDE; PROTEIN KINASE B; FOCAL ADHESION KINASE 1; NITRIC OXIDE DONOR;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; EXPOSURE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG NON SMALL CELL CANCER; MORPHOLOGICAL TRAIT; PLASMID; CELL DEATH; CELL MOTION; CELL SURVIVAL; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; LUNG TUMOR; METABOLISM; PATHOLOGY; PSEUDOPODIUM; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE; TUMOR INVASION; DRUG EFFECTS;

CAVEOLIN 1; CELL DEATH; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; ENZYME ACTIVATION; FOCAL ADHESION KINASE 1; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NITRIC OXIDE; NITRIC OXIDE DONORS; PROTO-ONCOGENE PROTEINS C-AKT; PSEUDOPODIA; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84883193137     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/186972     Document Type: Article

References (39)

1. Hanahan D., Weinberg R. A., The hallmarks of cancer. Cell 2000 100 1 57 70 2-s2.0-0034614637 10.1016/S0092-8674(00)81683-9
2. Manda G., Nechifor M. T., Neagu T.-M., Reactive oxygen species, cancer and anti-cancer therapies. Current Chemical Biology 2009 3 1 22 46 2-s2.0-65549116046
3. Keibel A., Singh V., Sharma M. C., Inflammation, microenvironment, and the immune system in cancer progression. Current Pharmaceutical Design 2009 15 17 1949 1955 2-s2.0-68449087605 10.2174/138161209788453167
4. Lala P. K., Chakraborty C., Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncology 2001 2 3 149 156 2-s2.0-0035296203 10.1016/S1470-2045(00)00256-4
5. Masri F., Role of nitric oxide and its metabolites as potential markers in lung cancer. Annals of Thoracic Medicine 2010 5 3 123 127 2-s2.0-77954858670 10.4103/1817-1737.65036
6. Masri F. A., Comhair S. A. A., Koeck T., Xu W., Janocha A., Ghosh S., Dweik R. A., Golish J., Kinter M., Stuehr D. J., Erzurum S. C., Aulak K. S., Abnormalities in nitric oxide and its derivatives in lung cancer. American Journal of Respiratory and Critical Care Medicine 2005 172 5 597 605 2-s2.0-24144500806 10.1164/rccm.200411-1523OC
7. Esme H., Cemek M., Sezer M., Saglam H., Demir A., Melek H., Unlu M., High levels of oxidative stress in patients with advanced lung cancer. Respirology 2008 13 1 112 116 2-s2.0-38049165726 10.1111/j.1440-1843.2007.01212.x
8. Geho D. H., Bandle R. W., Clair T., Liotta L. A., Physiological mechanisms of tumor-cell invasion and migration. Physiology 2005 20 3 194 200 2-s2.0-20444371524 10.1152/physiol.00009.2005
9. Mina L. A., Sledge G. W. Jr., Rethinking the metastatic cascade as a therapeutic target. Nature Reviews Clinical Oncology 2011 8 6 325 332 2-s2.0-79958038840 10.1038/nrclinonc.2011.59
10. Parri M., Chiarugi P., Rac and Rho GTPases in cancer cell motility control. Cell Communication and Signaling 2010 8 23 1 14 2-s2.0-77956459044 10.1186/1478-811X-8-23
11. Nobes C. D., Hall A., Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995 81 1 53 62 2-s2.0-0028961293
12. Serrels B., Serrels A., Brunton V. G., Holt M., McLean G. W., Gray C. H., Jones G. E., Frame M. C., Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex. Nature Cell Biology 2007 9 9 1046 1056 2-s2.0-34548316989 10.1038/ncb1626
13. Cary L. A., Chang J. F., Guan J.-L., Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. Journal of Cell Science 1996 109 7 1787 1794 2-s2.0-0029948080
14. Mitra S. K., Hanson D. A., Schlaepfer D. D., Focal adhesion kinase: in command and control of cell motility. Nature Reviews Molecular Cell Biology 2005 6 1 56 68 2-s2.0-11244258882 10.1038/nrm1549
15. Allen W. E., Jones G. E., Pollard J. W., Ridley A. J., Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. Journal of Cell Science 1997 110 6 707 720 2-s2.0-0030940218
16. Kaibuchi K., Kuroda S., Amano M., Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annual Review of Biochemistry 1999 68 459 486 2-s2.0-0032860424 10.1146/annurev.biochem.68.1.459
17. Williams T. M., Lisanti M. P., Caveolin-1 in oncogenic transformation, cancer, and metastasis. American Journal of Physiology-Cell Physiology 2005 288 3 C494 C506 2-s2.0-13644266312 10.1152/ajpcell.00458.2004
18. Chanvorachote P., Nimmannit U., Lu Y., Talbott S., Jiang B.-H., Rojanasakul Y., Nitric oxide regulates lung carcinoma cell anoikis through inhibition of ubiquitin-proteasomal degradation of caveolin-1. Journal of Biological Chemistry 2009 284 41 28476 28484 2-s2.0-70350514910 10.1074/jbc.M109.050864
19. Luanpitpong S., Talbott S. J., Rojanasakul Y., Nimmannit U., Pongrakhananon V., Wang L., Chanvorachote P., Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1. Journal of Biological Chemistry 2010 285 50 38832 38840 2-s2.0-78649859750 10.1074/jbc.M110.124958
20. Rungtabnapa P., Nimmannit U., Halim H., Rojanasakul Y., Chanvorachote P., Hydrogen peroxide inhibits non-small cell lung cancer cell anoikis through the inhibition of caveolin-1 degradation. American Journal of Physiology-Cell Physiology 2011 300 2 C235 C245 2-s2.0-79251534997 10.1152/ajpcell.00249.2010
21. Pongjit K., Chanvorachote P., Caveolin-1 sensitizes cisplatin-induced lung cancer cell apoptosis via superoxide anion-dependent mechanism. Molecular and Cellular Biochemistry 2011 358 1-2 365 373 2-s2.0-84857164349
22. Chunhacha P., Pongrakhananon V., Rojanasakul Y., Chanvorachote P., Caveolin-1 regulates Mcl-1 stability and anoikis in lung carcinoma cells. American Journal of Physiology-Cell Physiology 2012 302 9 C1284 C1292 2-s2.0-84860521179 10.1152/ajpcell.00318.2011
23. Songserm T., Pongrakhananon V., Chanvorachote P., Sub-toxic cisplatin mediates anoikis resistance through hydrogen peroxide-induced caveolin-1 up-regulation in non-small cell lung cancer cells. Anticancer Research 2012 32 5 1659 1669
24. Halim H., Luanpitpong S., Chanvorachote P., Acquisition of anoikis resistance up-regulates caveolin-1 expression in human non-small cell lung cancer cells. Anticancer Research 2012 32 5 1649 1658
25. Suchaoin W., Chanvorachote P., Caveolin-1 attenuates hydrogen peroxide-induced oxidative damage to lung carcinoma cells. Anticancer Research 2012 32 2 483 490 2-s2.0-84856908670
26. Chunhacha P., Chanvorachote P., Roles of caveolin-1 on anoikis resistance in non small cell lung cancer. International Journal of Physiology, Pathophysiology and Pharmacology 2012 4 3 149 155
27. Ho C.-C., Huang P.-H., Huang H.-Y., Chen Y.-H., Yang P.-C., Hsu S.-M., Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. American Journal of Pathology 2002 161 5 1647 1656 2-s2.0-0036841790
28. Sotgia F., Martinez-Outschoorn U. E., Howell A., Pestell R. G., Pavlides S., Lisanti M. P., Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annual Review of Pathology: Mechanisms of Disease 2012 7 423 467 2-s2.0-84855434874 10.1146/annurev-pathol- 011811-120856
29. Terranova V. P., Hujanen E. S., Loeb D. M., Martin G. R., Thornburg L., Glushko V., Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. Proceedings of the National Academy of Sciences of the United States of America 1986 83 2 465 469 2-s2.0-0001393245
30. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 2005 55 2 74 108 2-s2.0-14944385553
31. Paesmans M., Sculier J. P., Libert P., Bureau G., Dabouis G., Thiriaux J., Michel J., Van Cutsem O., Sergysels R., Mommen P., Klastersky J., Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. Journal of Clinical Oncology 1995 13 5 1221 1230 2-s2.0-0029030143
32. Moncada S., Higgs A., The L-arginine-nitric oxide pathway. The New England Journal of Medicine 1993 329 27 2002 2012 2-s2.0-0027752805 10.1056/NEJM199312303292706
33. Sarkar R., Meinberg E. G., Stanley J. C., Gordon R. D., Webb R. C., Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circulation Research 1996 78 2 225 230 2-s2.0-0030033842
34. Chen A., Kumar S. M., Sahley C. L., Muller K. J., Nitric oxide influences injury-induced microglial migration and accumulation in the leech CNS. Journal of Neuroscience 2000 20 3 1036 1043 2-s2.0-0034143431
35. Dhar A., Brindley J. M., Stark C., Citro M. L., Keefer L. K., Colburn N. H., Nitric oxide does not mediate but inhibits transformation and tumor phenotype. Molecular Cancer Therapeutics 2003 2 12 1285 1293 2-s2.0-4444361445
36. Fukumura D., Kashiwagi S., Jain R. K., The role of nitric oxide in tumour progression. Nature Reviews Cancer 2006 6 7 521 534 2-s2.0-33745559710 10.1038/nrc1910
37. Hickok J. R., Sahni S., Mikhed Y., Bonini M. G., Thomas D. D., Nitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: role of chelatable iron. Journal of Biological Chemistry 2011 286 48 41413 41424 2-s2.0-82355171937 10.1074/jbc.M111.287052
38. Polytarchou C., Hatziapostolou M., Poimenidi E., Mikelis C., Papadopoulou A., Parthymou A., Papadimitriou E., Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase β / ζ International Journal of Cancer 2009 124 8 1785 1793 2-s2.0-62449267453 10.1002/ijc.24084
39. Turečková J., Vojtěchová M., Krausová M., Šloncová E., Korínek V., Focal adhesion kinase functions as an akt downstream target in migration of colorectal cancer cells. Translational Oncology 2009 2 4 281 290